Zomedica Pharmaceuticals Corp (ZOM)

$0.22 0.01 (5.87%)

20:00 EDT ZOM Stock Quote Delayed 30 Minutes

Dogs Win, Investors Lose With Zomedica

By Dana Blankenhorn, InvestorPlace Contributor Mar 24, 2022

Zomedica said last year that Truforma would revolutionize veterinary care with radio waves. Now it would rather talk about PulseVet, which it bought in October

It’s Going to Take a Lot to Get Zomedica Stock Out of the Doghouse

Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica?

Zomedica’s Shareholders Should Be Worried About the Outlook of ZOM Stock

Volume:

Previous Close -

Market Cap 215.58M

PE Ratio -11.58

EPS -0.019

Volume (Avg. Vol.) 41.58M

Day's Range $0.20 - $0.22

52-Week Range $0.18 - $0.81

Dividend & Yield N/A (N/A)

ZOM Stock Predictions, Articles, and Zomedica Pharmaceuticals Corp News

From InvestorPlace
From the Web

Zomedica Stock Should Have Popped on This Latest Acquisition, so Beware

By Josh Enomoto, InvestorPlace Contributor Jan 21, 2022

Although ZOM stock has some exciting news to undergird its price tag, that hardly anything has changed is worrying.

There’s a Reason to Consider Buying Zomedica, and It’s a Real Shocker

By David Moadel, InvestorPlace Contributor Jan 7, 2022

ZOM stock is far from a market darling, but an underreported acquisition could breathe new life into Zomedia's struggling business.

Zomedica Remains a Speculative Play in the Veterinary Field

By Muslim Farooque Jan 4, 2022

The dismal run of ZOM Stock likely to continue for the foreseeable future, until it meaningfully improves its top and bottom-line numbers.

Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022

By Chris Markoch Dec 16, 2021

Retail investors continue to drive the price of meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022

7 Tempting Stocks to Avoid Until These Key Issues Get Ironed Out

By Thomas Niel Dec 9, 2021

Someday, the challenges and hurdles affecting them could clear up. But for now, consider this group of seven popular plays stocks to avoid.

Penny Stocks to Watch: What’s Going on With ZOM, DARE, PSFE, EFOI and AUUD Today?

By William White, InvestorPlace Writer Dec 8, 2021

Penny stocks are still a hot topic among retail traders and we're covering some of the top ones to watch Wednesday that are on the move.

Zomedica Stock Looks Tempting Here, But There’s Likely More Downside

By Chris Markoch Dec 3, 2021

Early in 2021, ZOM stock was part of the meme stock trade. But recent catalysts suggest it may be time to view it as an investment.

Zomedica Is Languishing Today, but Keep an Eye on This Risky Play

By Louis Navellier and the InvestorPlace Research Staff Nov 17, 2021

It's a risky play no doubt, but ZOM stock stands to get out of its current rut as a key temporary issue subsides.

7 Penny Stocks That Could Have an Explosive Year-End

By Thomas Niel Nov 5, 2021

While meme trends are on the wane, these seven penny stocks still stand to make turbocharged moves higher in the short-term.

Pet Stocks Alert: What Is Going on With PETZ and ZOM Stocks Today?

By Joel Baglole Nov 4, 2021

Speculative pet stocks TDH Holdings and Zomedica are jumping higher in morning trading but investors should be skeptical of the moves.

6 of the Hottest Stocks to Pick Up for Less Than $1

By Muslim Farooque Nov 1, 2021

These penny stocks are trading for under a dollar, but could change that in the coming months with their strong fundamentals.

Stay Away From Zomedica for These 3 Key Reasons

By Stavros Georgiadis, CFA, InvestorPlace Contributor Oct 25, 2021

ZOM stock had its best days in early 2021, but now its weak financial performance fully justifies its price weakness.

Zomedica Management Finally Delivers Some Good News

By Will Ashworth, InvestorPlace Contributor Oct 21, 2021

Zomedica's acquisition is precisely what was needed to get ZOM stock out of its lethargy. Long-term, it could be a game-changer. Here’s why.

Zomedica Stock Will Need More Than a Change in Management to Bounce Back

By Josh Enomoto, InvestorPlace Contributor Oct 13, 2021

While a C-suite scenery change might be good for Zomedica, the shift may not provide a similar outcome for ZOM stock.

New CEO and Acquisition Could Breathe New Life Into Zomedica

By Louis Navellier and the InvestorPlace Research Staff Oct 11, 2021

A turnaround in ZOM stock may happen sooner rather than later as Zomedica undergoes an executive-level change and builds out its business.

Zomedica Has Potential, but It’s Far Too Expensive for Now

By Muslim Farooque Oct 7, 2021

ZOM stock can be a pet care industry leader, but it needs to make significant improvements before becoming a solid long-term play.

The Challenges for Zomedica Continue, But It Still Has Huge Potential

By Louis Navellier and the InvestorPlace Research Staff Oct 7, 2021

Cautious investors may want to hold off, as no matter what direction it goes (higher or lower), it'll do so in a big way. But if you can stomach the risk, and have patience to wait out its current troubles, ZOM stock may be an opportunity.